< Back to previous page
Patent
Use of the GTPase Rab27B to diagnose and treat poor prognosis estrogen-receptor-positive breast can
Rab27B provides an important marker in the signature of ER-positief breast cancers with poor prognosis. This test can be used as a diagnostic tool as well as a therapeutic stratification tool by which risks assessments can be concluded
Patent Publication Number: WO2010130782
Year filing: 2010
Year approval: 2011
Year publication: 2010
Status: Requested
URI: link to Espacenet
Technology domains: undefined
Validated for IOF-key: Yes
Attributed to: Associatie Universiteit Gent